QQ客服 官方微博 反馈留言

浏览/检索结果: 共21条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A case of chemorefractory metastatic type AB thymoma sensitive to helical tomotherapy 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2019, 卷号: 7, 期号: 12 作者:  He, Zelai;  Zhang, Huijun;  Cui, Zhen;  Jing, Qijun;  Zhang, Zhe 收藏  |  浏览/下载：52/0  |  提交时间：2019/12/05 Thymoma  chemotherapy  radiotherapy  metastasis  tomotherapy (TOMO)   Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer 期刊论文 Cancer Letters, 2019, 卷号: 440-441, 页码: 180-188 作者:  Wang Z.;  Fu S.;  Zhao J.;  Zhao W.;  Shen Z. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11 Chemorefractory  Mitogen-activated protein kinase  Receptor tyrosine kinase  Small-cell lung cancer  Transbronchoscopic patient biopsy-derived xenografts   Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer 期刊论文 CANCER LETTERS, 2018, 卷号: 440, 页码: 180-188 作者:  Wang, Zhijie;  Fu, Shuai;  Zhao, Jun;  Zhao, Wei;  Shen, Zhirong 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/11 Transbronchoscopic patient biopsy-derived xenografts  Chemorefractory  Small-cell lung cancer  Mitogen-activated protein kinase  Receptor  tyrosine kinase   Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer 期刊论文 2018, 卷号: 440, 页码: 180-188 作者:  Wang, Zhijie;  Fu, Shuai;  Zhao, Jun;  Zhao, Wei;  Shen, Zhirong 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Transbronchoscopic patient biopsy-derived xenografts  Chemorefractory  Small-cell lung cancer  Mitogen-activated protein kinase  Receptor tyrosine kinase   Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia 期刊论文 2018, 卷号: 65, 页码: 20-24 作者:  Zhan, Di;  Zhang, Yingchi;  Xiao, Peifang;  Zheng, Xinchang;  Ruan, Min 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Primary chemo-resistance  Epigenetic regulator mutations  Pediatric leukemia  Whole exome sequencing   Outcomes by hypomagnesemia in the randomized phase III ASPECCT trial in patients with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC) 期刊论文 Journal of Clinical Oncology, 2016 作者:  Price T.J., Kim T.W., Li J., Cascinu S., Ruff P., Suresh A.V., Thomas A., Tjulandin S., Guan X., Peeters M. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/13 Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT: randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer 期刊论文 EUROPEAN JOURNAL OF CANCER, 2016, 卷号: 68 作者:  Price, Timothy;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano;  Ruff, Paul 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/06 Anti-EGFR therapy  Colorectal cancer  Gastrointestinal cancer  Panitumumab   Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs. cetuximab (cmab) in pts with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC). 会议论文 作者:  Price, Timothy Jay;  Newhall, Kathryn;  Peeters, Marc;  Kim, Tae Won;  Li, Jin 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/13 Randomized phase 3 study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): outcomes by hypomagnesemia (hypomag) in ASPECCT 会议论文 作者:  Peeters, Marc;  Price, Timothy Jay;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/13 Randomized phase III study of panitumumab (pmab) vs. cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT. 会议论文 作者:  Price, Timothy Jay;  Peeters, Marc;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/13